Method for administering sedative
By using earplugs or eye patches to block external stimuli during regional anesthesia, the sedative dosage can be reduced, addressing anxiety and side effect issues, resulting in more effective and safer sedation with propofol administration.
Patent Information
- Application Number
- PCT/KR2023/006054
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2023-05-03
- Publication Date
- 2024-11-07
AI Technical Summary
Current methods for administering sedatives during regional anesthesia face challenges such as excessive dosage requirements, respiratory depression, hypotension, and increased anxiety due to external stimuli like noise and light, which can lead to complications like postoperative pain and prolonged hospitalization.
Administering sedatives to regionally anesthetized patients while they wear earplugs or an eye patch to block external stimuli, reducing the sedative dose needed and minimizing side effects like apnea and hypotension, as demonstrated by the use of earplugs and eye masks during spinal anesthesia with propofol administration.
This method reduces the sedative dosage required, shortens the time to achieve adequate sedation, lowers the incidence of apnea, and decreases the risk of hypotension, while improving patient satisfaction and reducing postoperative complications.
Smart Images

Figure KR2023006054_07112024_PF_FP_ABST
Abstract
Description
How to administer sedatives
[0001] The present invention relates to a method for administering a sedative.
[0002]
[0003] Intravenous sedation is commonly administered during regional anesthesia to reduce patient anxiety and increase comfort during surgery. Perioperative anxiety is not limited to simple psychological stress; it can lead to various complications, including increased postoperative pain and analgesic requirements, and prolonged hospital stays. However, sedatives have significant side effects and must be administered cautiously. Intravenous sedation can cause respiratory depression and hypotension during surgery, necessitating close patient monitoring and prompt treatment to avoid medical emergencies. Therefore, non-pharmacological interventions that can help reduce sedative dosage and patient anxiety are clinically important.
[0004] Environmental factors must be considered to maintain adequate sedation during surgery. Bright operating room lighting and surgical noise can interfere with a patient's ability to rest and impede proper sedation. Previous studies have shown that earplugs and eye masks, used to reduce external noise and light stimuli, improved patients' sleep quality and reduced the incidence of postoperative disorientation. Previous studies have also shown that playing music to patients through headphones can reduce anxiety and sedative requirements during spinal anesthesia. However, whether blocking external noise and light stimuli without music can help patients remain calm during surgery has not been investigated. The present invention demonstrates that wearing earplugs and an eye mask during regional anesthesia blocks external stimuli, relaxes the patient, and reduces the dose of sedative needed to maintain adequate sedation.
[0005]
[0006] An object of the present invention is to provide a method for administering a sedative that can provide a sufficient sedative effect to a patient under regional anesthesia while reducing the dosage of the sedative.
[0007]
[0008] 1. A method for administering a sedative, comprising the step of administering a sedative to a patient under regional anesthesia while the patient wears earplugs or an eye patch.
[0009] 2. In the above 1, the local anesthesia is spinal anesthesia, a method of administering a sedative.
[0010] 3. A method of administering a sedative, wherein the sedative is propofol in the above 1.
[0011]
[0012] The administration method of the present invention can reduce the dosage of a sedative administered to a patient under regional anesthesia.
[0013] The administration method of the present invention can further reduce the time required for the BIS (Bispectral Index) value to reach 80 or less after administration of a sedative compared to a patient not wearing earplugs or an eye patch.
[0014] The administration method of the present invention can further reduce the incidence of apnea during surgery compared to patients who do not wear earplugs or eye patches.
[0015] The administration method of the present invention can further reduce the possibility of hypotension due to sedation during surgery compared to patients who do not wear earplugs or eye patches.
[0016]
[0017] Figure 1 illustrates a flow chart for classifying patients into control and experimental groups.
[0018]
[0019] Hereinafter, the present invention will be described in detail.
[0020] The present invention provides a method for administering a sedative, comprising the step of administering a sedative to a patient under regional anesthesia while the patient wears an earplug or an eye patch.
[0021] Regional anesthesia involves administering an anesthetic to a specific area of the body while the patient is conscious, chemically blocking nerve conduction in the nerve endings running through that area, thereby eliminating pain. Compared to general anesthesia, regional anesthesia offers advantages: no anesthetic device is required, the patient breathes independently, and fewer complications related to the circulatory or respiratory system. However, because the patient remains conscious, it can cause anxiety, making it difficult to administer to children. Furthermore, because motor nerves are not blocked, it is not appropriate for situations requiring minimal movement.
[0022] In the case of regional anesthesia, since the patient is conscious, a sedative can be administered to provide a calming effect during surgery. However, excessive use of sedatives can lead to complications, so it is important to administer the sedative in an appropriate dosage. The present invention blocks external stimuli to the patient, thereby providing high-quality sedation while reducing the dosage of sedative compared to patients not wearing earplugs or eye patches.
[0023] The above regional anesthesia can be performed by any method known to those skilled in the art. For example, methods for performing the above regional anesthesia can include surface anesthesia, infiltration anesthesia, nerve block, and spinal anesthesia, and are preferably, but not limited to, spinal anesthesia.
[0024] The patient may include any human subject requiring administration of local anesthesia and sedation. For example, the subject may be, but is not limited to, a human subject undergoing orthopedic surgery.
[0025] The above earplugs are intended to block out noise from the operating room to the patient. Any earplug commonly used in the art may be used without limitation as long as it can reduce noise.
[0026] The above-mentioned eye patch is intended to block light stimulation to the patient in the operating room. Any eye patch commonly used in the art can be used without limitation as long as it can block light stimulation.
[0027] The wearing of the earplugs or eye patch can be performed using methods commonly used in the art, and is not limited thereto. Furthermore, the timing of wearing the earplugs or eye patch is not limited. For example, it may include before regional anesthesia, during regional anesthesia, or after regional anesthesia but before administration of sedatives. Preferably, it is after regional anesthesia but before administration of sedatives, but is not limited thereto.
[0028] The above sedatives include all sedatives commonly used in the art to induce a sedative effect in patients undergoing regional anesthesia. Examples include midazolam, demerol, pethidine, and propofol, preferably propofol, but are not limited thereto.
[0029] The above sedative may be administered by any method conventional in the art. For example, it may be administered by intravenous injection, subcutaneous injection, intramuscular injection, or epidural injection, and is preferably administered intravenously, but is not limited thereto.
[0030]
[0031] Example
[0032] 1. Experimental method
[0033] This prospective, randomized controlled trial was approved by the Institutional Review Board of Seoul National University Bundang Hospital (Study Number: B2102-664-309) and registered in the University Hospital Medical Information Network Clinical Trial Registry (Registration Number: UMIN000043496). The trial adhered to the CONSORT guidelines. Written informed consent was obtained from all patients before surgery. Patients were enrolled in the medical registry of Seoul National University Bundang Hospital from March 25, 2021, to August 4, 2022.
[0034]
[0035] 1-1. Patient recruitment
[0036] This study enrolled adult patients aged 19 to 64 years with American Society of Anesthesiologists physical status I or II scheduled for elective orthopedic surgery under spinal anesthesia. Patients receiving general or epidural anesthesia and those with a history of heart failure, respiratory failure, sleep apnea, or propofol allergy were excluded. Patients who did not wish to use intravenous sedation, earplugs, or eye patches during surgery were also excluded. Patients undergoing procedures requiring lateral decubitus positioning because they could not wear earplugs were also excluded. Patients requiring intensive care unit admission after surgery were also excluded. Participants were randomly assigned 1:1 to the control or experimental group using a computer-generated random code (Random Allocation Software Version 1.0; University of Medical Sciences, Isfahan, Iran). Randomization was performed by an anesthesiologist who was solely responsible for patient assignment and sedation score assessment.
[0037]
[0038] 1-2. Spinal anesthesia and sedation
[0039] After the patients entered the operating room, standard monitoring was initiated using electrocardiogram, noninvasive blood pressure, peripheral oxygen saturation, and bispectral index (BIS; Medtronic, Dublin, Ireland). Spinal anesthesia was induced by intrathecal injection of optimal doses of 0.5% hyperbaric bupivacaine together with 10–20 μg of fentanyl through a 26G Quincke needle at the L3-4 or L4-5 interspace. After confirming adequate sensory block and hemodynamic stability, earplugs (Optime 105, 3M, Saint Paul, MI, USA) and eye masks (Dreamweaver-Contoured Sleep Mask, MACK'S, Michigan, IN, USA) were placed on the ears and eyes of the experimental group patients. In the control group, earplugs and eye masks were not used. The eye masks were disposable and discarded, and cleaned with an alcohol-based cleanser. Intravenous sedation was administered after placing the earplugs and eye masks. Target-controlled infusions (TCIs) of propofol were performed using an Orchestra infusion pump system (Fresenius vial, Berzins, France). The initial target effect-site concentration (ESC) was set at 1.2 μg / mL.
[0040] During sedation, the Modified Observer's Assessment of Alertness and Sedation (MOAA / S) was independently assessed every 10 minutes by the anesthesiologist responsible for the assigned patient. For the experimental group, the earplug was slightly elevated from the left ear to assess sedation. The MOAA / S score was defined as follows: readily responds to name spoken in a normal tone; lethargic responds to name spoken in a normal tone; responds only after name is spoken loudly and / or repeatedly; responds only after gentle prodding or shaking; and does not respond to gentle prodding or shaking. The target sedation score was 3 or 4, and the effect-site concentration was adjusted every 10 minutes according to the MOAA / S score as follows: if the score was 3 or 4, the concentration was maintained the same; if the MOAA / S score was 2 or less, the patient's effect-site concentration was reduced by 0.2 μg / mL. During surgery, when mean blood pressure (MBP) decreased by more than 20% from baseline or fell below 60 mmHg, 10-20 μg of phenylephrine was administered intravenously. If the heart rate fell below 40 beats per minute, 0.5 mg of atropine was administered.
[0041]
[0042] 1-3. Evaluation method
[0043] The first result was the total propofol dose and patient weight. -1 ·Administration time -1 (mg·kg -1 ·h -1) for the total propofol requirement during surgery. MBP, heart rate, BIS score, and target effect site concentration of propofol were recorded every 10 minutes during surgery. The time taken for the BIS value to reach 80 or less from the start of propofol administration was called the induction time. The incidence of sedation-induced apnea and intraoperative inotropic requirements were also recorded. A blinded investigator asked the patients to independently rate their satisfaction with intraoperative sedation using a numeric rating scale (score: 0, very dissatisfied, 10, very satisfied) 24 hours after surgery. The incidence of nausea and vomiting during the first 24 hours after surgery was also investigated.
[0044]
[0045] 1-4. Statistical analysis methods
[0046] Continuous data were presented as median (interquartile range), and categorical variables were presented as numbers (percentiles). The Mann-Whitney U test was used to compare continuous outcomes between the control and experimental groups. Categorical outcomes were analyzed using the chi-square or Fisher exact test. All statistical analyses were performed using SPSS version 21.0 (SPSS Inc., IBM, Chicago, IL, USA). Statistical significance was defined as a two-sided p-value of <0.05.
[0047]
[0048] 1-5. How to calculate sample size
[0049] In a pilot study of 20 patients (10 in each group) undergoing orthopedic surgery under spinal anesthesia, the mean (standard deviation) propofol requirement was 3.3 (0.8) mg·kg in the control group and 2.8 (0.7) mg·kg in the experimental group. -1 ·h -1Based on the pilot study results, a power analysis was performed using G*Power 3.1.2 (Heinrich-Heine University, Düsseldorf, Germany). A sample size of 40 patients per group was calculated to ensure 80% statistical power, considering a 0.05 risk of type I error and a 10% dropout rate in a two-sided analysis.
[0050]
[0051] 2. Experimental Results
[0052] Of the 83 eligible patients, three declined to participate in the study, leaving 80 patients randomly assigned to the control group (n = 40) or the experimental group (n = 40). The anesthesia method was changed to general anesthesia for one patient in each group. Two patients in the control group and one patient in the experimental group declined to participate before spinal anesthesia. Therefore, the study was conducted on 75 patients (37 in the control group and 38 in the experimental group; Figure 1 ).
[0053] Patient characteristics did not differ between the two groups (Table 1). Surgical data, including operation / sedation time, spinal anesthesia, and type of surgery, did not differ between the groups (Table 2). The intraoperative propofol requirement for controlled sedation was significantly lower in the experimental group than in the control group (2.3 (2.0-2.7) vs. 3.1 (2.7-3.4) mg·kg). -1 ·h -1 ; p < 0.001; Table 3). The mean effective site concentration of propofol was also lower in the experimental group than in the control group during surgery (0.9 (0.8–1.1) vs. 1.2 (1.1–1.4) mcg·mL -1; p < 0.001). The mean BIS did not differ significantly between the groups (p = 0.478). The induction time was shorter in the experimental group than in the control group (190.0 (120.0-321.0) vs. 280.0 (180.0-452.0) seconds, p = 0.006). The incidence of intraoperative apnea was significantly lower in the experimental group (3 vs. 11, p = 0.038). The incidence of postoperative nausea and vomiting was similar between the two groups (p = 0.190). Patient satisfaction with intraoperative sedation was significantly higher in the experimental group than in the control group (10.0 (9.0-10.0) vs. 8.0 (8.0-10.0), p = 0.002).
[0054]
[0055] Control group (n=37) Experimental group (n=38) p-value Age (years) 52.0 (39.0-60.0) 54.5 (41.0-61.8) 0.248 Male (n) 16 18 0.720 Weight (kg) 68.0 (64.0-85.0) 74.1 (63.9-83.4) 0.618 Height (cm) 163.0 (156.0-168.0) 162.5 (155.1-170.6) 0.93 1 ASA gradeⅠ / Ⅱ 17 / 2018 / 20 0.90 2 Values are presented as median (IQR) or number. ASA, American Society of Anesthesiologist.
[0056]
[0057] Control group (n=37) Experimental group (n=38) p-value Surgical time, min 125.0(105.0-165.0) 115.0(106.3-173.8) 0.706 Sedation time, min 86.0(70.0-120.0) 80.0(60.0-108.8) 0.257 Intrathecal bupivacaine dose, mg 13.0(11.3-13.0) 12.5(12.0-13.8) 0.494 Intrathecal fentanyl dose, mcg 20.0(15.0-20.0) 15.0(10.0-20.0) 0.177 Type of surgery, nTKRA 68 0.264 Knee arthroscopic surgery 1517 Ankle arthroscopic surgery 57 ORIF 63 etc. 153 Values are expressed as median (IQR) or numbers. TKRA, total knee replacement arthroplasty; ORIF, open reduction and internal fixation. 1 The group consisted of a small number of cases with a variety of procedures, including wound debridement, osteotomy, bulk resection, and total ankle replacement.
[0058]
[0059] Control group (n=37) Experimental group (n=38) Odds ratio (95% CI) p-value Propofol dose, mg·kg -1 ·h -1 3.1(2.7-3.4)2.3(2.0-2.7)-<0.001Average propofol effect site concentration, μg mL -1 1.2(1.1-1.4)0.9(0.8-1.1)-<0.001Average BIS76.3(74.2-79.8)75.9(73.5-79.0)-0.478Induction time, s280.0(180.0-452.0)190.0(120.0-321.0)-0.006Base MBP, mmHg81.0(74.0-89.0)79.5(75.0-94.9)-0.379Average MBP, mmHg75.1(69.5-78.9)77.3(72.9-86.1)-0.036Base Heart rate, beats / min 71.0 (59.0-76.0) 66.0 (60.0-77.0) - 0.461 Mean heart rate, beats / min 61.9 (58.2-67.2) 63.4 (56.0-71.9) - 0.546 Number of times vasopressors were needed, n 1720 1.3 (0.5-3.2) 0.563 Occurrence of apnea, n 1130.3 (0.1-1.0) 0.038 PONV, n 840.4 (0.1-1.6) 0.190 Patient satisfaction 8.0 (8.0-10.0) 10.0 (9.0-10.0) - 0.002 Values are presented as median (IQR) or number. BIS, bispectral index; MBP, mean blood pressure; PONV (postoperative nausea and vomiting), postoperative nausea and vomiting.
[0060]
[0061] Baseline MBP and heart rate were similar between the control and experimental groups (p = 0.379 and 0.461, respectively; Table 4). However, intraoperative MBP was significantly higher in the experimental group than in the control group (77.3 (72.9–96.1) vs. 75.1 (69.5–78.9) mmHg; p = 0.036). There was no significant difference in mean heart rate between the two groups during surgery (p = 0.546), nor was intraoperative muscle contraction demand (p = 0.563).
[0062]
[0063] Control group experimental group p-value high noise level 1 N=12N=11-Propofol dose, mg·kg -1 ·h -1 3.3(3.1-3.5)2.4(2.2-2.6)<0.001Average propofol effect site concentration, μg·mL -1 1.2(1.2-1.2)0.8(0.8-1.0)0.023Low noise level 2 N=20N=24-Propofol dose, mg·kg -1 ·h -1 3.0(2.6-3.4)2.2(1.9-2.6)<0.001Average propofol effect site concentration, μg·mL -1 1.0(0.8-1.2)0.8(0.6-1.0)0.001Values are expressed as median (IQR). High noise level 1 Subgroups include total knee arthroplasty and open reduction / internal fixation. Low noise level. 2 Subgroups include knee and ankle arthroscopic surgeries.
[0064]
[0065] Subgroup analyses of propofol use were also performed for high and low noise levels (Table 4). Propofol doses were significantly lower in the intervention group than in the control group during orthopedic surgery, both at low and high noise levels (both p<0.001). Similarly, mean target propofol concentrations during surgery were lower in the intervention group than in the control group at both noise levels (p=0.023 and 0.001 for high and low noise levels, respectively).
Claims
1. A method for administering a sedative, comprising the step of administering a sedative to a patient under local anesthesia while wearing earplugs or an eye patch.
2. A method for administering a sedative according to claim 1, wherein the regional anesthesia is spinal anesthesia.
3. A method for administering a sedative according to claim 1, wherein the sedative is propofol.
Citation Information
Patent Citations
Eye patch for protecting eyes when surgery
KR200475620Y1
